TWO:NYSETwo Harbors Investment Corp Analysis
Data as of 2026-05-06 - not real-time
$12.25
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Two Harbors is trading at $12.25, comfortably above its 20‑day ($11.35), 50‑day ($10.74) and 200‑day ($10.53) SMAs, and the MACD line sits bullish over its signal (0.35 vs 0.23). However, the RSI of 70.6 flags an overbought condition and the 30‑day volatility of ~30% combined with a low beta (~0.48) suggests price swings could be sharp despite modest market‑wide correlation.
Fundamentally, the REIT posts a negative profit margin (-69%) and a steep debt‑to‑equity ratio of 479, while delivering an eye‑catching 11.5% dividend yield that appears unsustainable given negative earnings and limited free cash flow. Recent news shows competing acquisition offers—CrossCountry at $11.30 and UWM at $12.00 per share—both below the current market price, creating uncertainty over a potential deal premium or a price correction toward those levels.
Fundamentally, the REIT posts a negative profit margin (-69%) and a steep debt‑to‑equity ratio of 479, while delivering an eye‑catching 11.5% dividend yield that appears unsustainable given negative earnings and limited free cash flow. Recent news shows competing acquisition offers—CrossCountry at $11.30 and UWM at $12.00 per share—both below the current market price, creating uncertainty over a potential deal premium or a price correction toward those levels.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI indicating overbought conditions
- Uncertainty around competing acquisition offers
- High dividend yield may be unsustainable
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Pending outcome of CrossCountry vs. UWM bids
- Leverage and negative cash‑flow constraints
- Potential price correction toward offer levels
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- Attractive long‑term yield if cash flow stabilizes
- Asset base of MSRs and RMBS provides steady income
- Interest‑rate environment and low beta mitigate broader market risk
Key Metrics & Analysis
Financial Health
Revenue Growth1569.10%
Profit Margin-69.46%
P/E Ratio10.6
ROE-17.69%
ROA-2.83%
Debt/Equity479.18
P/B Ratio1.1
Op. Cash Flow$33.6M
Industry P/E32.8
Technical Analysis
TrendBullish
RSI70.6
Support$10.96
Resistance$12.67
MA 20$11.35
MA 50$10.74
MA 200$10.53
MACDBullish
VolumeIncreasing
Fear & Greed Index90.38
Valuation
Target Price$11.28
Upside/Downside-7.96%
GradeUndervalued
TypeValue
Dividend Yield11.50%
Risk Assessment
Beta0.48
Volatility30.61%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.